Kummer, Oliver <br/><br/>
Effect of the inhibition of CYP3A4 or CYP2D6 on the pharmacokinetics and pharmacodynamics of oxycodone.  [electronic resource] 

 -  European journal of clinical pharmacology  Jan 2011 
 - 63-71 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1432-1041 
<br/><br/><label>Standard No.: </label>10.1007/s00228-010-0893-3  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Analgesics, Opioid--adverse effects<br/>Cross-Over Studies<br/>Cytochrome P-450 CYP2D6 Inhibitors<br/>Cytochrome P-450 CYP3A<br/>Cytochrome P-450 CYP3A Inhibitors<br/>Double-Blind Method<br/>Drug Interactions<br/>Genotype<br/>Humans<br/>Ketoconazole--pharmacology<br/>Miosis<br/>Morphinans--metabolism<br/>Oxycodone--adverse effects<br/>Oxymorphone--metabolism<br/>Pain Measurement<br/>Paroxetine--pharmacology<br/>Placebos<br/>Young Adult